| | | | | | | | | | | | | | | | | | | | | | Years Ended (In Millions, Except Per Share Amounts) | | Dec 27, 2025 | | Dec 28, 2024 | | Dec 30, 2023 | | Net income (loss) | | $ | 26 | | | $ | (19,233) | | | $ | 1,675 | | | Less: net income (loss) attributable to non-controlling interests | | 293 | | | (477) | | | (14) | | | Net income (loss) attributable to Intel | | $ | (267) | | | $ | (18,756) | | | $ | 1,689 | | Weighted average shares of common stock outstanding—basic1 | | 4,530 | | | 4,280 | | | 4,190 | | Dilutive effect of employee equity incentive plans and stock issuances | | — | | | — | | | 22 | | | Weighted average shares of common stock outstanding—diluted | | 4,530 | | | 4,280 | | | 4,212 | | | Earnings (loss) per share attributable to Intel—basic | | $ | (0.06) | | | $ | (4.38) | | | $ | 0.40 | | Earnings (loss) per share attributable to Intel—diluted | | $ | (0.06) | | | $ | (4.38) | | | $ | 0.40 | |
1 For the year ended December 27, 2025, we have included the weighted average impacts of Escrowed Shares that are not contingently issuable. Refer to additional discussion under the U.S. Government Agreements section below.
|